[go: up one dir, main page]

AR039172A1 - MORFOLINA DERIVATIVES, CCR3 ANTAGONISTS. - Google Patents

MORFOLINA DERIVATIVES, CCR3 ANTAGONISTS.

Info

Publication number
AR039172A1
AR039172A1 ARP030101084A ARP030101084A AR039172A1 AR 039172 A1 AR039172 A1 AR 039172A1 AR P030101084 A ARP030101084 A AR P030101084A AR P030101084 A ARP030101084 A AR P030101084A AR 039172 A1 AR039172 A1 AR 039172A1
Authority
AR
Argentina
Prior art keywords
morfolina
derivatives
ccr3 antagonists
substituted
alkyl
Prior art date
Application number
ARP030101084A
Other languages
Spanish (es)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AR039172A1 publication Critical patent/AR039172A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Ciertos compuestos de fórmula (1): en la que: R1 representa arilo sustituido o no sustituido; Y representa -(CRnaRnb)n-; Rna y Rnb son cada uno independientemente hidrógeno o alquilo C1-6; n es un número entero de 1 a 5; R2 representa arilo sustituido o no sustituido o heteroarilo sustituido o no sustituido; cada uno de R3 y R4 representa independientemente hidrógeno o alquilo C1-6; y sales y solvatos de los mismos son antagonistas de CCR3 y, de esta forma, están indicados por su utilidad en terapia.Certain compounds of formula (1): in which: R 1 represents substituted or unsubstituted aryl; Y represents - (CRnaRnb) n-; Rna and Rnb are each independently hydrogen or C1-6 alkyl; n is an integer from 1 to 5; R2 represents substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl; each of R3 and R4 independently represents hydrogen or C1-6 alkyl; and salts and solvates thereof are CCR3 antagonists and, thus, are indicated by their usefulness in therapy.

ARP030101084A 2002-03-28 2003-03-27 MORFOLINA DERIVATIVES, CCR3 ANTAGONISTS. AR039172A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0207436.7A GB0207436D0 (en) 2002-03-28 2002-03-28 Novel compounds

Publications (1)

Publication Number Publication Date
AR039172A1 true AR039172A1 (en) 2005-02-09

Family

ID=9933988

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101084A AR039172A1 (en) 2002-03-28 2003-03-27 MORFOLINA DERIVATIVES, CCR3 ANTAGONISTS.

Country Status (7)

Country Link
EP (1) EP1487455A1 (en)
JP (1) JP2005526807A (en)
AR (1) AR039172A1 (en)
AU (1) AU2003226759A1 (en)
GB (1) GB0207436D0 (en)
TW (1) TW200400824A (en)
WO (1) WO2003082292A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028948A1 (en) 2000-06-20 2003-05-28 Astrazeneca Ab NEW COMPOUNDS
KR100966749B1 (en) 2004-05-26 2010-06-30 에자이 알앤드디 매니지먼트 가부시키가이샤 Cinnamid compounds
WO2006028284A1 (en) 2004-09-08 2006-03-16 Mitsubishi Pharma Corporation Morpholine compound
AU2005297966B2 (en) 2004-10-26 2010-12-23 Eisai R & D Management Co., Ltd. Amorphous object of cinnamide compound
TW200744612A (en) * 2005-08-26 2007-12-16 Astrazeneca Ab New combination
MX2008002320A (en) * 2005-08-26 2008-03-14 Astrazeneca Ab A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma.
TWI370130B (en) 2005-11-24 2012-08-11 Eisai R&D Man Co Ltd Two cyclic cinnamide compound
TWI386207B (en) 2005-11-24 2013-02-21 Eisai R&D Man Co Ltd Morpholine type cinnamide compound
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
AU2007252643A1 (en) * 2006-05-19 2007-11-29 Eisai R & D Management Co., Ltd. Urea type cinnamide derivative
AR062095A1 (en) 2006-07-28 2008-10-15 Eisai R&D Man Co Ltd CINAMIDE COMPOUND PROFARMACO
WO2008103126A1 (en) * 2007-02-23 2008-08-28 Astrazeneca Ab Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma
TW200848054A (en) 2007-02-28 2008-12-16 Eisai R&D Man Co Ltd Two cyclic oxomorpholine derivatives
EP2181992B8 (en) 2007-08-31 2013-06-26 Eisai R&D Management Co., Ltd. Polycyclic compound
US7935815B2 (en) 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970703301A (en) * 1994-05-18 1997-07-03 쇼오다 오사무 Novel Diaminomethylidene Derivatives (NOVEL DIAMINCMETHYLIDENE DERIVATIVE)
WO2000031032A1 (en) * 1998-11-20 2000-06-02 F. Hoffmann-La Roche Ag Pyrrolidine derivatives-ccr-3 receptor antagonists
HUP0303107A2 (en) * 2000-09-29 2004-03-01 Glaxo Group Ltd. Compounds useful in the treatment of inflammatory diseases, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU2003226759A1 (en) 2003-10-13
GB0207436D0 (en) 2002-05-08
JP2005526807A (en) 2005-09-08
WO2003082292A1 (en) 2003-10-09
EP1487455A1 (en) 2004-12-22
TW200400824A (en) 2004-01-16

Similar Documents

Publication Publication Date Title
AR039172A1 (en) MORFOLINA DERIVATIVES, CCR3 ANTAGONISTS.
CY1111706T1 (en) Aryl- and heteroaryl-piperidinocarboxylate derivatives, their preparation and their application as FAAH enzyme inhibitors
CO5580746A2 (en) DERIVATIVES OF PHENYL-PIPERAZINE AS INHIBITORS OF THE REABSORTION OF SEROTONINE
CO5580768A2 (en) DERIVATIVES OF 4,5-DIARILTIAZOL AS LIGANDOS CB-1
CY1106237T1 (en) ETEOCYCLIC DERIVATIVES WITH 5 MEMBERED RING AND THEIR APPLICATION AS INHIBITORS OF MONOAMINO OXIDATION
HUP9802859A2 (en) Acylaminosalicylic acid amides and their uses as pesticides
EA200970311A1 (en) DERIVATIVES 2-ARYL-6-PHENYLIMIDAZO [1,2-α] Pyridine, THEIR RECEIVING AND APPLICATION IN THERAPY
EA200401285A1 (en) SINTERED WITH RADIOACTIVE ISOTOPES OF QUINOLINE AND QUINOLINOIN DERIVATIVES AND THEIR APPLICATION AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTOR
EA200800285A1 (en) NEW DERIVATIVES 2,4-DIANILINOPIRIMIDINES, THEIR PRODUCTION, MEDICINES, PHARMACEUTICAL COMPOSITIONS, CONTAINING INDICATED DERIVATIVES, AND THEIR APPLICATION, IN PARTICULAR, AS THE PROTECTIVE.
EA200600509A1 (en) COMPOUNDS OF PYRIMIDOTHIOPHENE
ECSP045369A (en) DERIVATIVES OF N- [PHENYL (PIPERIDIN-2-IL) METIL] BENZAMIDA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
UY26899A1 (en) FUSIONATED PIRAZOL DERIVATIVES
AR049784A1 (en) SUBSTITUTED DERIVATIVES OF MORFOLINA AND TIOMORFOLINA
NO20076006L (en) acetylene Derivatives
CO4520230A1 (en) DERIVATIVES OF [3- (4-PHENYLPIPERACIN-1-IL) PROPYLAMINE, UNCLE AND OXYL] -PIRIDINE, PYRIMIDINE AND BENZENE AS ALPHA ANTAGONISTS 1- ADRENOCEPTORS
DK1117297T3 (en) Synthetic analogues of ecteinascidin-743
ECSP045278A (en) OXO-AZABYCLIC COMPOUNDS
WO2003082861A3 (en) Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
HRP20090474T1 (en) PROCEDURE AND INTERMEDIATES FOR SYNTHESIS OF KASPOFUNGIN
AR024939A1 (en) COMPOUNDS DERIVED FROM HIDANTOINE, THIOHYDANTOINE, PYRIMIDINONES, THIOXOPIRIMIDINONES, INTERMEDIARIES, PROCESS FOR THEIR PREPARATION AND ITS USE OF THEM
AR042362A1 (en) DERIVATIVES OF 3H-QUINAZOLIN-4-ONA, PROCESS OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR040133A1 (en) DERIVATIVES OF N-ACILAMINO BENCIL ETER
ATE402185T1 (en) METHOD FOR FLUORCYTIDINE DERIVATIVES
MY143216A (en) Synthetic multiple quaternary ammonium salts
HUP0201475A2 (en) Heteroaryl amidines, methylamidines and guanidines their preparation and use and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FB Suspension of granting procedure